Revenue: The sum of all revenue fields included for a company's operating activities.
Perspective Therapeutics, Inc. (CATX) had Revenue of $0.34M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$0.34M |
$-18.18M |
|
-- |
|
$0.34M |
|
$22.17M |
|
$-21.83M |
|
$3.65M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-21.83M |
|
$-22.09M |
|
72.36M |
|
72.36M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$215.74M |
|
$61.25M |
|
$113.61M |
|
$329.35M |
|
$12.68M |
|
$1.61M |
|
$32.02M |
|
$44.70M |
|
$284.64M |
|
$234.65M |
|
$284.64M |
|
74.05M |
|
| Cash Flow Statement Financials | |
$-21.58M |
|
$-5.57M |
|
$9.97M |
|
$61.58M |
|
$44.41M |
|
$-17.17M |
|
$2.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.02 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-6383.63% |
|
-6383.63% |
|
-- |
|
-5314.91% |
|
-5314.91% |
|
$-26.24M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
4.38 |
|
20.53 |
|
-6.39% |
|
-7.75% |
|
-5.52% |
|
-6.35% |
|
$3.84 |
|
$-0.36 |
|
$-0.30 |
|